Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sayre, PA
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sayre, PA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Germantown, TN
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Irving, TX
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Irving, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Southlake, TX
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Southlake, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tyler, TX
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
West Jordan, UT
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chesapeake, VA
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fairfax, VA
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Roanoke, VA
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
mi
from
Bedford,
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
mi
from
Bedford,
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1119
mi
from
Birmingham, AL
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1119
mi
from
Birmingham, AL
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1133
mi
from
Dothan, AL
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1133
mi
from
Dothan, AL
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1107
mi
from
Hollywood, FL
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1107
mi
from
Hollywood, FL
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1123
mi
from
Naples, FL
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1123
mi
from
Naples, FL
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1106
mi
from
Port Orange, FL
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1106
mi
from
Port Orange, FL
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1137
mi
from
Sweetwater, FL
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1137
mi
from
Sweetwater, FL
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1131
mi
from
Chicago, IL
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1131
mi
from
Chicago, IL
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1127
mi
from
Urbana, IL
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1127
mi
from
Urbana, IL
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1113
mi
from
Chevy Chase, MD
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1113
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1111
mi
from
Troy, MI
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1111
mi
from
Troy, MI
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1109
mi
from
Great Neck, NY
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1109
mi
from
Great Neck, NY
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1114
mi
from
Rochester, NY
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1114
mi
from
Rochester, NY
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1118
mi
from
Raleigh, NC
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1118
mi
from
Raleigh, NC
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1112
mi
from
Cincinnati, OH
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1112
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1105
mi
from
Germantown, TN
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1105
mi
from
Germantown, TN
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1102
mi
from
Hermitage, TN
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1102
mi
from
Hermitage, TN
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1136
mi
from
DeSoto, TX
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1136
mi
from
DeSoto, TX
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1121
mi
from
Houston, TX
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1121
mi
from
Houston, TX
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1116
mi
from
Temple, TX
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1116
mi
from
Temple, TX
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1103
mi
from
Ogden, UT
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1103
mi
from
Ogden, UT
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1130
mi
from
Richmond, VA
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1130
mi
from
Richmond, VA
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1128
mi
from
Roanoke, VA
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1128
mi
from
Roanoke, VA
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1115
mi
from
Seattle, WA
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1115
mi
from
Seattle, WA
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1101
mi
from
Seattle, WA
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1101
mi
from
Seattle, WA
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1108
mi
from
Wauwatosa, WI
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1108
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1143
mi
from
Thousand Oaks, CA
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1143
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1138
mi
from
Miami, FL
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1138
mi
from
Miami, FL
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1141
mi
from
Orlando, FL
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1141
mi
from
Orlando, FL
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1139
mi
from
Hoffman Estates, IL
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1139
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1142
mi
from
Traverse City, MI
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1142
mi
from
Traverse City, MI
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1117
mi
from
Pittsburgh, PA
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1117
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Arena 1604
mi
from
Kingswood,
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Arena 1604
mi
from
Kingswood,
Click here to add this to my saved trials
Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of Mesalamine 4 g Extended Release Granules (Sachet) for the Induction of Clinical and Endoscopic Remission in Active, Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
IMIC
mi
from
Palmetto Bay, FL
Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of Mesalamine 4 g Extended Release Granules (Sachet) for the Induction of Clinical and Endoscopic Remission in Active, Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
IMIC
mi
from
Palmetto Bay, FL
Click here to add this to my saved trials